Solid Dosage
Anti-virals
GEA supplies solutions for manufacturing inhalable and oral antiviral drugs ranging from blending, spray drying and particle engineering to continuous manufacturing.
Manufacturing Anti-virals
Antiviral medications help the body to fight off harmful viruses such as influenza, chickenpox and the human immunodeficiency virus (HIV), to name a few. The drugs can ease symptoms and shorten the length of a viral infection. Antivirals also lower the risk of getting or spreading viruses that cause herpes and HIV. One approved antiviral treats the coronavirus that causes COVID-19.
Antiviral drugs are also preventive. They can protect you from getting viral infections or spreading a virus to others. They come in many formats, including tablets, intravenous solutions, liquids and inhaled powders.
For inhalable versions, GEA understands that homogeneity and stability are key factors. Our dry powder blending, spray drying and particle engineering capabilities ensure that the production of free-flowing, aerodynamic particles at the correct size is achievable at the scale you need.
And, with the ongoing development of oral anti-viral medications, particularly as a result of the COVID-19, pandemic, there is increased interest in the use of continuous manufacturing to accelerate process design and product optimization.
For example, the compact and fully integrated ConsiGma®4.0 platform has been designed to transfer powder into coated tablets in a shorter time frame. Plus, by combining Quality by Design (QbD) principles with Design of Experiments (DoE), it enables operators to explore the design space in a quick and easy way and expedite time-to-market.
Produits et technologies
Affichage de 4 sur 26
Automatisation des procédés
En tant qu’intégrateurs de systèmes, nous associons notre savoir faire en matière de technologie de process et d'engineering aux logiciels de contrôle commande et de supervision développés par des leaders du marché.
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Granulation Lines
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Downloads
GEA Insights
Reality check for biotech
The new GEA Application and Technology Center (ATC) in Sarstedt, south of Hannover, is neither a showroom nor a substitute for a lab. It is a place for testing, data collection and early decisions. This is where it becomes clear whether a biological concept can become a robust industrial process. That step is bigger than it may seem.
L'évolution des emballages alimentaires en 4 tendances
Si le thermoformage joue depuis longtemps un rôle central dans le domaine de l'emballage alimentaire, il doit aujourd'hui affronter un tournant majeur. À une époque comme la nôtre où les réglementations se durcissent, où les matériaux évoluent et où les coûts augmentent, il ne suffit plus que les lignes de conditionnement FFS ou <i>Form-Fill-Seal</i> (Former-Remplir-Sceller) fonctionnent de manière fiable : elles sont désormais déterminantes pour garantir la fraîcheur des denrées, un prix accessible et la recyclabilité. Examinez de plus près les grandes tendances qui dans le domaine du thermoformage façonnent le secteur de l'emballage et de la distribution alimentaires.
